Goldman Sachs Upgrades Boston Scientific To Neutral

Loading...
Loading...
Analysts at Goldman Sachs upgraded Boston Scientific
BSX
from Sell to Neutral. The price target for Boston Scientific has been raised from $11.00 to $13.00. Boston Scientific shares have gained 6.76% over the past 52 weeks, while the S&P 500 index has surged 9.99% in the same period. Boston Scientific's shares closed at $12.32 in after-hours trading.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesAnalyst RatingsGoldman Sachs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...